MLL defends Lipomed’s deferiprone business

MLL represented Lipomed AG and Lipomed GmbH in patent opposition proceedings before the Board of Appeal of the European Patent Office and coordinated the international patent litigation concerning Lipomed’s deferiprone business, an iron chelating agent, which removes excess iron from the body.

The MLL team was led by Simon Holzer (pictured) and Ulrike Ciesla.

MLL defends Lipomed’s deferiprone business


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram